Assignee
ASURAGEN INC
US·19 granted patents·23 pending applications·398 citations·filing 2005–2021
Top patents by PatentIndex Score
42 records- 0198US9506061B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Nov 29, 2016·165 cites·7 claims
- 0296US7960359B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2007·Granted Jun 14, 2011·37 cites·17 claims
- 0396US7919245B2Methods and compositions involving microRNAASURAGEN INC·Filed 2007·Granted Apr 5, 2011·67 cites·13 claims
- 0496US7888010B2Methods and compositions involving microRNAASURAGEN INC·Filed 2005·Granted Feb 15, 2011·78 cites·14 claims
- 0589US8003320B2Methods and compositions involving MicroRNAASURAGEN INC·Filed 2007·Granted Aug 23, 2011·8 cites·9 claims
- 0689US7993831B2Methods of normalization in microRNA detection assaysASURAGEN INC·Filed 2007·Granted Aug 9, 2011·28 cites·24 claims
- 0785US9447414B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2015·Granted Sep 20, 2016·2 cites·3 claims
- 0885US9051571B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 9, 2015·3 cites·28 claims
- 0985US8765709B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2013·Granted Jul 1, 2014·3 cites·22 claims
- 1083US9382537B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jul 5, 2016·2 cites·10 claims
- 1183US9068219B2Methods and compositions involving miRNA and miRNA inhibitor moleculesASURAGEN INC·Filed 2014·Granted Jun 30, 2015·2 cites·33 claims
- 1280US11236384B2Methods of RNA amplificationASURAGEN INC·Filed 2018·Granted Feb 1, 2022·1 cites·24 claims
- 1374US8361714B2Micrornas differentially expressed in cervical cancer and uses thereofASURAGEN INC·Filed 2008·Granted Jan 29, 2013·1 cites·13 claims
- 1473US9080215B2MicroRNAs differentially expressed in cervical cancer and uses thereofASURAGEN INC·Filed 2013·Granted Jul 14, 2015·1 cites·19 claims
- 1571US12139755B2Methods of RNA amplificationASURAGEN INC·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
- 1667US2017037404A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2016·Application pending·0 cites
- 1767US2013303591A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 1866US2013143945A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2013·Application pending·0 cites
- 1965US9783848B2PCR methods for characterizing the 5′ untranslated region of the FMR1 and FMR2 genesASURAGEN INC·Filed 2014·Granted Oct 10, 2017·0 cites·52 claims
- 2064US2015361431A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2164US2022136044A1Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating a/t-rich segmentsASURAGEN INC·Filed 2021·Application pending·0 cites
- 2263US2015342981A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2363US2015284720A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2463US2015344883A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2563US2015299705A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2663US2015284719A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2763US2015275213A1Methods and compositions involving mirna and mirna inhibitor moleculesASURAGEN INC·Filed 2015·Application pending·0 cites
- 2859US2014141423A1miRNAs Differentially Expressed in Lymph Nodes from Cancer PatientsASURAGEN INC·Filed 2013·Application pending·0 cites
- 2957US11214829B2Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segmentsASURAGEN INC·Filed 2016·Granted Jan 4, 2022·0 cites·35 claims
- 3055US2009092974A1Micrornas differentially expressed in leukemia and uses thereofASURAGEN INC·Filed 2007·Application pending·0 cites
- 3155US2014274791A1miRNA BIOMARKERS OF LUNG DISEASEASURAGEN INC·Filed 2014·Application pending·0 cites
- 3254US11913068B2Methods for nucleic acid size detection of repeat sequencesASURAGEN INC·Filed 2019·Granted Feb 27, 2024·0 cites·10 claims
- 3354US2021189384A1Methods and compositions for amplicon concatenationASURAGEN INC·Filed 2020·Application pending·0 cites
- 3453US9371560B2Comprehensive FMR1 genotypingASURAGEN INC·Filed 2013·Granted Jun 21, 2016·0 cites·25 claims
- 3553US2013142728A1Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumorsASURAGEN INC·Filed 2012·Application pending·0 cites
- 3651US2008131878A1Compositions and Methods for the Detection of Small RNAASURAGEN INC·Filed 2006·Application pending·0 cites
- 3751US2014100124A1Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesionsASURAGEN INC·Filed 2013·Application pending·0 cites
- 3848US2009258928A1Methods and compositions for diagnosing and modulating human papillomavirus (hpv)ASURAGEN INC·Filed 2009·Application pending·0 cites
- 3947US2009131356A1miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTIONASURAGEN INC·Filed 2008·Application pending·0 cites
- 4044US2017121763A1Methods for nucleic acid size detection of repeat sequencesASURAGEN INC·Filed 2016·Application pending·0 cites
- 4140US2013157884A1Methods and compositions involving mirna expression levels for distinguishing pancreatic cystsASURAGEN INC·Filed 2012·Application pending·0 cites
- 4237US2018163261A1Methods and apparatuses for improving mutation assessment accuracyASURAGEN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASURAGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →